The factors that drive the global dengue vaccine market are rising prevalence of this epidemic, increasing novel drug treatment, convenience of direct purchase, affordability of vaccine, high adoption and acceptance in developing markets, and innovations and developments in vaccine.

Dengue Vaccine Market Size and Growth Rate:

Dengue Vaccine Market was valued USD 0.22 billion in 2016 and is expected to reach USD 1.15 billion by 2024 at a CAGR of 17% over the forecast period.

Browse 280 pages of the detailed report and TOC @ https://www.researchcosmos.com/reports/global-dengue-vaccine-market-analysis-and-forecast-2016-2024-industry-growth-opportunities/5935471

Dengue Vaccine Market Growth Drivers and Restraints:

The factors that drive the dengue vaccine market are rising prevalence of dengue, increasing novel drug treatment, convenience of purchase, affordability of vaccine, high adoption and acceptance in developing markets, and innovations and developments in vaccine. The market also faces some limitations, such as the fierce competition among existing players to develop a new vaccine, the high risk of side effects of the vaccine, the complications and severity associated with taking incorrect medications due to misdiagnosis, population rural development and underdeveloped economies.

Geographical Presence of Dengue Vaccine Market:

Geographically, the dengue vaccine market has been segmented into five main regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. North America is the largest market for dengue vaccine in terms of income, followed by Europe. The United States has the largest market share in the region. Asia Pacific and Latin America are emerging markets that are expected to experience strong growth during the forecast period from 2017 to 2025. The strong growth in these regions is attributed to the rising incidence of dengue, the growth of the health care sector and the increase of public investment to expand the health care infrastructure. The dengue vaccine market in countries such as China, India and Brazil, is expected to grow at a high growth rate during the forecast period due to increased public awareness of the disease and its treatment.

Avail Sample of the report for more information @ https://www.researchcosmos.com/request/global-dengue-vaccine-market-analysis-and-forecast-2016-2024-industry-growth-opportunities/5935471

Key Players of Dengue Vaccine Market:

Some of the leading market players of Dengue Vaccine Market are Sanofi Pasteur, Biological E. Limited, Merck & Co., Glaxosmithkline, Pfizer, Panacea Biotech Ltd., Vabiotech, Butantan Institute and others.

Dengue Vaccine Market Segmentation:

By Technology:

• Live attenuated vaccine
• Chimeric Live attenuated vaccine
• Subunit vaccine
• Inactivated vaccine
• Nucleic acid based vaccine

By End Users:

• Hospital
• Diagnostic Labs
• NGO’s
• Government Institutes

By Region:

• North America
• South America
• Europe
• Asia Pacific
• Middle East and Africa

Make an Inquiry before buying @ https://www.researchcosmos.com/inquire/global-dengue-vaccine-market-analysis-and-forecast-2016-2024-industry-growth-opportunities/5935471

About Us:

Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.

Contact:

Kevin Stewart

Global Sales Manager

Research Cosmos

www.researchcosmos.com

Blog: https://acutemarketinsights.com

Blog: https://marketreportsweb.com/

kevin@researchcosmos.com

+1 888 709 8757